Injunction On Apotex Reinstated In Fortical IP Suit

Law360, New York (July 7, 2010, 7:05 PM EDT) -- A federal judge has reinstated a decision that bars generics maker Apotex Corp. from infringing two Unigene Laboratories Inc.-held patents for Fortical nasal spray, rejecting affirmative defenses and counterclaims that the defendant claimed were not addressed in the original order.

Judge Robert P. Patterson Jr. of the U.S. District Court for the Southern District of New York issued the order Tuesday, pointing out that Apotex might be using its stronger economic position to bury Unigene under litigation and force the company into a settlement.

Fortical is...
To view the full article, register now.